Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The week ahead sees Apple (AAPL) host its annual WWDC conference, Walmart (WMT) hol...
--Agreement expands reach of industry-leading Horizon DXA system-- Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with DEXA+ to distribute Hologic’s Horizon ® DXA system for body composition measurement. With over 20 years of experience...
--Improved accuracy in identifying bacterial vaginosis (BV), vulvovaginal candidiasis (Candida vaginitis, CV) and trichomoniasis (Trichomonas vaginalis, TV) will enable more targeted treatment for women-- Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance ...
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers' 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers' regulatory 13F Form filed on 05/06/2019. Please visit our Tracking Kahn Brothers Portfolio series to get an idea ...
The following slide deck was published by Hologic, Inc. in conjunction with this Read more ...
Company to host timely educational panel on breast density featuring leading clinicians Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women's health and well-being, will showcase its comprehensive portfolio of healthcare solution...
Hologic, Inc. (HOLX) Q2 2019 Results Conference Call May 01, 2019 04:30 PM ET Company Participants Mike Watts - VP, IR and Corporate Communications Steve MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Tycho Peterson - JP Morgan ...
Hologic (NASDAQ: HOLX ) fiscal Q2 results ($M): Revenues: 818.4 (+3.7%); product sales: 667.8 (+3.5%). More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Breast health leader will highlight expanding portfolio for breast conserving surgery Hologic, Inc. (Nasdaq: HOLX) will showcase its growing breast surgery franchise, which includes products such as the new Trident® HD specimen radiography system, LOCalizer ™ wire-free gu...
Company expands breast specimen imaging portfolio and leadership in breast cancer diagnosis and care Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident ® HD specimen radiography system, a next-generation solution that delivers enhanced ima...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...